Source:http://linkedlifedata.com/resource/pubmed/id/18024883
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
33
|
pubmed:dateCreated |
2007-11-20
|
pubmed:commentsCorrections | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Nov
|
pubmed:issn |
1527-7755
|
pubmed:author | |
pubmed:issnType |
Electronic
|
pubmed:day |
20
|
pubmed:volume |
25
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
5331-2; author reply 5334-5
|
pubmed:meshHeading |
pubmed-meshheading:18024883-Antineoplastic Agents,
pubmed-meshheading:18024883-Biological Availability,
pubmed-meshheading:18024883-Drug Administration Schedule,
pubmed-meshheading:18024883-Drug Labeling,
pubmed-meshheading:18024883-Food-Drug Interactions,
pubmed-meshheading:18024883-Humans,
pubmed-meshheading:18024883-Quinazolines
|
pubmed:year |
2007
|
pubmed:articleTitle |
The value of label recommendations: how to dose lapatinib.
|
pubmed:publicationType |
Letter,
Comment
|